Contact us for more information or to book your assessment visit!

Find the specialized Gondola® Partner Center nearest you and book an appointment to assess your treatment response.

I am a*
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

News and Updates on Parkinson's Disease

  • All
  • GONDOLA
  • Other
  • Parkinson
  • Peripheral Neuropathy
  • Stroke
All
  • All
  • GONDOLA
  • Other
  • Parkinson
  • Peripheral Neuropathy
  • Stroke
MDS Congress

MDS Congress 2020

At Gondola Medical Technologies, we are honored to take part this week in the International Congress of Parkinson’s Disease and ...

Read more

Swiss Movement Disorders Symposium

Gondola Medical Technologies is proud to sponsor the Swiss Movement Disorders Symposium and to contribute to improve the health of ...

Read more

Stroke Leaders Highlight the Global Cost of Government Inertia

On World Stroke Day, October 29, the World Stroke Organization Calls for Urgent Action and Investment to Address the Rising ...

Read more

A New Movement Disorder Treatment Arrives in France!

Introducing Gondola AMPS, the New Therapy for Gait Disorders Caused by Neurological Conditions like Parkinson's, Stroke, Coming from Southern ...

Read more

GONDOLA at the 2019 International Parkinson Congress

The countdown has begun for the 2019 International Congress on Parkinson's Disease and Movement Disorders. The event will indeed take ...

Read more

GONDOLA will participate in the TechShare program 2019/2020.

TechShare is a pre-IPO (Initial Public Offering) program launched by Euronext in 2015, which helps entrepreneurs become familiar with the ...

Read more

Stroke rehabilitation: what to expect during recovery

The goal of stroke rehabilitation is to help you relearn the skills you lost after the event. Stroke rehabilitation can ...

Read more

MADOPAR, what to know on this drug for Parkinson’s Disease

This article answers to the most common questions on MADOPAR. It doesn't provide all the information and, most important, ...

Read more

Parkinson and Stroke with GONDOLA, the device for movement disorders.

Gondola has not defeated Parkinson's disease but has significantly improved the quality of life of Parkinson's patients. It is also ...

Read more

Welcome to the News section of Gondola Medical, your go-to resource for the latest news and insights on Parkinson’s disease. In this section, we cover a wide range of topics relevant to patients, caregivers, and healthcare professionals.

You will find articles dedicated to exercise and Parkinson’s, where you can discover the benefits of physical activity in managing symptoms and receive practical advice on how to incorporate specific exercises into your daily routine. We delve into the topic of freezing of gait, exploring the causes of this common symptom and the available therapies to improve mobility. Patient testimonials, who have experienced significant improvements in their quality of life thanks to Gondola AMPS therapy, offer a real and encouraging perspective.

We analyze the impact of Parkinson’s on social interactions and work abilities, offering suggestions on how to cope with these daily challenges. Stay updated on global and local initiatives for World Parkinson’s Day, with details on important events and conferences. We provide information on exercises and therapies to address bradykinesia, improving movement and motor control.

A comprehensive review of AMPS therapy highlights its benefits in managing gait problems related to Parkinson’s. Additionally, we explore the complementary role of Automated Mechanical Peripheral Stimulation (AMPS) and Deep Brain Stimulation (DBS) in the treatment of advanced Parkinson’s. Finally, we offer information on new calls for the purchase of technologically advanced aids, including Gondola AMPS devices, to support disabled people or their families.

Browse our news to stay informed about the latest discoveries and innovative solutions in Parkinson’s treatment, with the aim of improving your daily life and that of your loved ones.